Cost-effectiveness of a machine learning risk prediction model (LungFlag) in the selection of high-risk individuals for non-small cell lung cancer screening in Spain.

Journal: Journal of medical economics
PMID:

Abstract

OBJECTIVE: The LungFlag risk prediction model uses individualized clinical variables to identify individuals at high-risk of non-small cell lung cancer (NSCLC) for screening with low-dose computed tomography (LDCT). This study evaluates the cost-effectiveness of LungFlag implementation in the Spanish setting for the identification of individuals at high-risk of NSCLC.

Authors

  • Juan Carlos Trujillo
    Thoracic Surgery Department, Hospital de la Santa Creu i Sant Pau and Hospital del Mar, Barcelona, Spain.
  • Joan B Soriano
    Instituto de Investigación Hospital de la Princesa, Universidad Autónoma de Madrid, Madrid, Spain.
  • Mercè Marzo
    Cancer Research Group in Primary Health Care Catalan Health Institut, Barcelona, Spain.
  • Oliver Higuera
    Medical Oncology, Hospital Universitario La Paz, Madrid, Spain.
  • Luis Gorospe
    Radiodiagnostic Service, Hospital Universitario Ramón y Cajal, Madrid, Spain.
  • Virginia Pajares
    Thoracic Surgery Department, Hospital de la Santa Creu i Sant Pau and Hospital del Mar, Barcelona, Spain.
  • María Eugenia Olmedo
    Medical Oncology, Hospital Universitario Ramón y Cajal, Madrid, Spain.
  • Natalia Arrabal
    Pricing, Roche Farma SA, Madrid, Spain.
  • Andrés Flores
    Medical Affairs, Roche Farma SA, Madrid, Spain.
  • José Francisco García
    Medical Affairs, Roche Farma SA, Madrid, Spain.
  • María Crespo
    HEOR, Hygeia Consulting SL, Madrid, Spain.
  • David Carcedo
    HEOR, Hygeia Consulting SL, Madrid, Spain.
  • Carolina Heuser
    Global Access Evidence, Hoffman-la Roche, Basel, Switzerland.
  • Milan M S Obradović
    Medical Affairs, Hoffman-la Roche, Basel, Switzerland.
  • Nicolò Olghi
    Digital Health Business Lead, Hoffman-la Roche, Basel, Switzerland.
  • Eran N Choman
    Medial EarlySign, Hod HaSharon, Israel.
  • Luis M Seijo
    Clínica Universidad de Navarra, Pamplona, Spain.